ArticleClinical Medicine Insights. Oncology2022

Therapeutic Strategies for Resectable Stage-IIIA N2 Non-Small Cell Lung Cancer Patients: A Network Meta-Analysis.

Ziyang Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.